Articles

GOD BLESS AMERICA   SYMPOSIUM INFORMATION NOW AVAILABLE The overall goal of The Stanley Neurovirology Laboratory of The Johns Hopkins University School of Medicine is to develop a training and research program devoted to the elucidation of the role of infection and immunity in the etiology of schizophrenia and bipolar disorders. Symposium information Research Picture […]

Epigenetic Studies of Genomic Retroelements in Major Psychosis Pei-Xiang Kan, Violeta Popendikyte, Zachary A. Kaminsky, Robert H. Yolken, Arturas Petronis Schizophrenia Research 67 (2004) 95-106   Abstract This work is dedicated to the exploration of the role of epigenetic (epiG) factors in major psychosis.  One of the key functions of epigenetic modification of the genome

PUBLICATIONS OF THE STANLEY LABORATORY OF THE JOHNS HOPKINS UNIVERSITY Workshop on Schizophrenia Identification of Differentially Expressed RNA Transcripts in Neuopsychiatric Disorders Could Schizophrenia Be A Viral Zoonosis Transmitted From House Cats Metabolites of the Antipsychotic Agent Clozapine Inhibit the Replication of Human Immunodeficiency Virus Type 1 Viruses, Schizophrenia and Bipolar Disorder Viruses as Etiologic

ROBERT YOLKEN The basic goal of my research is to characterize the role of infectious and inflammatory processes in complex psychiatric disease such as schizophrenia, bipolar disorder, and autism. We also examine these processes in the context of gene-environmental interactions. The theoretical background of the studies can be found in the PowerPoint presentations (Schizophrenia and

APPLICATION FOR A FELLOWSHIP IN THE STANLEY DIVISION OF DEVELOPMENTAL NEUROVIROLOGY AT THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE Please note that this application cannot be completed on-line. You must print out the form to complete it. (To print a copy of the application please click on the above title) PLEASE BE SURE TO FOLLOW

THE STANLEY NEUROVIROLOGY LABORATORY AT THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE The overall goal of the Laboratory is to develop a training and research program devoted to the elucidation of the role of infection and immunity in the etiology of schizophrenia and bipolar disorders. Post-doctoral fellows in the Stanley Neurovirology Laboratory Fellowship Program will

METABOLITES OF THE ANTIPSYCHOTIC AGENT CLOZAPINE INHIBIT THE REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 Lorraine V. Jones-Brando, James L. Buthod, Louis E. Holland, Robert H. Yolken, E. Fuller Torrey Abstract Schizophrenia is a serious and often debilitating neuropsychiatric disease of worldwide importance. Current therapy relies on the use of typical antipsychotic medications, which specifically

DRUGS USED IN THE TREATMENT OF SCHIZOPHRENIA AND BIPOLAR DISORDER INHIBIT THE REPLICATION OF TOXOPLASMA GONDII Schizophrenia Research 62 (2003)237-244 Lorraine Jones-Brando, E. Fuller Torrey, Robert Yolken ABSTRACT: The exact mechanisms of action of some antipsychotics and mood stabilizers have not been elucidated. Response to these medications can vary among individuals. Recent studies indicate that

THE ASSOCIATION BETWEEN COGNITIVE FUNCTIONING AND OCCUPATIONAL STATUS IN PERSONS WITH A RECENT ONSET OF PSYCHOSIS J Nerv Ment Dis. 2007 Jul;195(7):566-71 Dickerson FB, Stallings C, Origoni A, Boronow JJ, Sullens A, Yolken R Stanley Research Program, Sheppard Pratt Health System, Baltimore, Maryland, USA. [email protected] ABSTRACT The ability to engage in occupational activity is an

LOW MATERNAL VITAMIN D AS A RISK FACTOR FOR SCHIZOPHRENIA: A PILOT STUDY USING BANKED SERA Schizophrenia Research 2003 Sept. 1;63(1-2):73-8 J McGrath, D Eyles, B Mowry, R Yolken, S Buka ABSTRACT: OBJECTIVE: Evidence from epidemiology suggests that low maternal vitamin D may be a risk factor for schizophrenia METHOD: Based on sera taken during